← Back to Search

Intensive lifestyle intervention for Type 2 Diabetes (ILIAD Trial)

N/A
Waitlist Available
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

ILIAD Trial Summary

This trial is testing a new way to help people with Type 2 diabetes, by providing an intensive lifestyle intervention virtually. The study will last for 24 weeks and include 15 virtual visits.

Eligible Conditions
  • Type 2 Diabetes

ILIAD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The of this study will be weight loss in the participants.

ILIAD Trial Design

1Treatment groups
Experimental Treatment
Group I: Intensive lifestyle interventionExperimental Treatment1 Intervention
Participants will undergo an intensive lifestyle intervention, implemented virtually by a medical team with expertise in the management of T2DM. This team will be made up of an endocrinologist, a nutritionist and a nurse.

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalOTHER
167 Previous Clinical Trials
107,157 Total Patients Enrolled
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,637 Total Patients Enrolled
Institut de Recherches Cliniques de MontrealOTHER
70 Previous Clinical Trials
10,368 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial accept individuals aged 45 and older as participants?

"This medical research accepts patients aged between 18 and 75, as those are the parameters outlined in its inclusion criteria."

Answered by AI

Is this trial still recruiting participants?

"As indicated on clinicaltrials.gov, this medical experiment is still recruiting participants; the trial was initially posted in October of 2021 and recently updated in July of 2022."

Answered by AI

How many volunteers are participating in this experiment?

"Affirmative. According to clinicaltrials.gov, this study first went live on October 14th 2021 and has since been updated in July 12th 2022. As of now, 16 patients from one medical centre are being sought after for the trial's recruitment process."

Answered by AI

To whom is enrollment in this study open?

"This clinical trial requires 16 individuals with type 2 diabetes who are being treated with insulin and aged 18 to 75. Eligible applicants must meet the following requirements: Age between 18-75, BMI of 27 to 45kg/m2, diagnosed T2DM for at least 5 years, HbA1c under 9.5% in last 3 months, access to internet & telephone, stable dose of GLP-1 for 6 months minimum, good autonomy managing medications & meals preparation."

Answered by AI
~0 spots leftby Apr 2025